Related Experiment Video
Updated: Oct 17, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
[Study of HCV infection and viremia in patients with posttransfusion hepatitis in China]
1Abteilung für Klinische Immunologie, Tongji Klinik, Tongji Medizinische Universität, Wuhan.
Insights
Hepatitis C virus (HCV) is the primary cause of posttransfusion hepatitis (PTH). While some patients also show Hepatitis B virus (HBV) markers, further research is needed on HCV and HBV interactions.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Posttransfusion hepatitis (PTH) remains a concern following blood transfusions.
- Identifying causative agents is crucial for effective prevention and treatment.
Purpose of the Study:
- To investigate the etiological agents of posttransfusion hepatitis (PTH) in 169 patients.
- To determine the detection timeframes for Hepatitis C virus (HCV) antibodies and RNA.
- To analyze the patterns of HCV viremia in a follow-up cohort.
Main Methods:
- Serological testing and Polymerase Chain Reaction (PCR) were employed.
- Detection of anti-HCV antibodies and HCV RNA.
- Follow-up serological and viremia assessments over 1.5 to 3 years.
Main Results:
- Hepatitis C virus (HCV) was identified as the predominant cause of PTH.
- Hepatitis B virus (HBV) markers were positive in 24 out of 169 patients.
- Anti-HCV antibodies appeared within 7 days to 1 year (average 54.62 days); HCV RNA was detected earlier (average 8.72 days).
- Follow-up revealed transient, persistent, or intermittent HCV viremia in all patients, with sustained anti-HCV positivity.
Conclusions:
- HCV is the main etiological agent in posttransfusion hepatitis.
- Early detection of HCV infection is possible through RNA testing.
- HCV viremia patterns vary, and the interplay with HBV requires further investigation.
Abstract:
One hundred and sixty-nine patients with posttransfusion hepatitis (PTH) were investigated for etiology with serological and PCR methods. Our result showed that HCV was the major causative agent of PTH in this study. A part of patients (24/169) were also HBV markers positive. Three patients were negative for all detected viral markers, looking forwards to progressive study. Anti-HCV was detectable from 7 days to one year after onsetting of clinical symptoms, average time 54.62 days. HCV RNA could be detected in early time of HCV infection ( 6 to 20 days later), average time 8.72 days. A follow-up study of 84 patients showed that all patients remained anti-HCV positive during the observation for 1.5 -- 3 years, but their HCV viremia had three forms: transient, persistent or intermittent. The interaction between HCV and HBV by their superinfection was unknown, awaiting further study.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction

